They looked at UK COVID cases with (n=208,947) and without (n=15,087) the dropout associated w Omicron, and perform regression analyses to see what factors could predict Omicron
Date, for one
3/ for example, to predict whether a case is Omicron, you could find a clue by whether they are a reinfection (breakthrough).
There were 4,100 reinfections, but 36% of them were in the dropout group, compared w only 7% of the total cases. (OR 6.55 after controlling for all else)
4/ there are lots of cases in the dataset, so you can include lots of variables in the regression.
But the number of hospitalized was low. Only 1,392 / 209,000 S+ cases ~ 0.7%
And the "Omicron" (S-) hospitalization rate was 24/15,087 ~ 0.15%
That's right. 24 cases total
5/ so the authors are correct in saying that whether a person got hospitalized is not useful for statistically predicting whether the case is Omicron or not, but that's mostly because there are so few hospitalized cases in the sample (and only 24 w Omicron).
6/ while raw percent showed 4x lower hosp rate among Omicron, after statistical accounting for multiple variables (eg Omicron cases more likely to be vaccinated), the rate of hospitalization between S+ and S- is essentially equivalent
But there are lots of entangled variables
7/ I would consider the Imperial study conclusion as
"we can't say if it's less severe or not"
Not
"Seems to be equivalent"
(I remain hopeful 🙏)
8/An example for caution on interpreting these multiple regression results w entangled variables, I don't actually believe that getting 2 doses of Pfizer is "NEGATIVELY protective" against Omicron, even if the statistical confidence limits don't include 1, and the p value is tiny
9/ key table is here
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/ Omicron is ripping through America right now, to an extent we won't fully realize until later
At this point, I think most people can hope to delay infection, but not to avoid it.
I don't think herd immunity is a realistic goal anymore
Here's what I think it means for us
2/ Even as the Delta wave continues to kill over a thousand people a day, Omicron is already here, and there is no reason to believe that the explosive growth we have seen in other countries, and in local outbreak (like Cornell University) isn't happening across the US already.
3/ an Intrinsic infectiousness that is perhaps 2-3 times higher than Delta, with a short incubation time, and at least some measure of immune escape- means that we are unlikely to get Rt below 1 (and the outbreak quenched) before it rips through a large proportion of susceptibles
We've often heard people say something like "this innovative new service/company is good for patients and saves money, but there's no business model for it/ current reimbursement doesn't support it"
Step 1: Let's generate examples:
2/ I'll start.
But this is a group exercise, I need your nominations. Please try to give suggestions with some evidence behind them
*Advanced Care Planning
*Hospital at home
*Diabetes prevention program
*"SDOH" care navigation
(Used to be, telehealth)
3/ great work, tweeple
Clearly no shortage of ideas (with varying level of evidence) for things that could save money and be good for patients
The view espoused by many (including yours truly) has been that these services will flourish under value-based care
2/ As the title implies, the best way to think about the problem is that Private Equity points the way towards every opportunity for outsized financial gains, especially where there is arbitrage, or market failures.
PE investors use the word "rents" in a positive way
3/ As @brianwpowers@WillShrank have pointed out, if you create outsized opportunities in new payment models, private capital can accelerated that too
Though IMO they undersell the degree to which PE-backed groups in MA tend to focus on...risk adjustment
Can we measure "likely unnecessary admissions" somehow?
...and to be clear, I am not sympathetic to the idea that we should somehow minimize the terrible negative impact of covid on hospitals and ICUs being full
2) it's true that good policy can align private profit with public good, but if we are going to rely on that, need tight surveillance and fast response from regulators to close arbitrage opportunities where short-term profit maximizers will gather. c/f surprise billing
3/ if you wait too long, then entrenched profits become normalized, powerful incumbents are formed, and they can, and will, exert political influence to keep the "status quo" in place.
Many health policy examples (facility fees, drug pricing). But also...Medicare Advantage 👀